Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 36Terminated 7Unknown 4Withdrawn 3Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Lymphoma, Large B-Cell, Diffuse 3Hodgkin Disease 3Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Uveal Melanoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pediatric Brain Tumor 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Follicular 1Lymphoma 1Glioblastoma 1Burkitt Lymphoma 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 30fludarabine 20Rituximab 15fludarabine phosphate 12obinutuzumab 8Specimen Handling 8Lenalidomide 7Immunotherapy, Adoptive 7ibrutinib 6Etoposide 6venetoclax 5polatuzumab vedotin 5pirtobrutinib 5glofitamab 5axicabtagene ciloleucel 5Whole-Body Irradiation 5Prednisone 5Mycophenolic Acid 5Melphalan 4Granulocyte Colony-Stimulating Factor 4Doxorubicin 4Blood Component Removal 4Biopsy 4pembrolizumab 3daratumumab 3X-Rays 3Vincristine 3Stem Cell Transplantation 3Interleukin-2 3Injections 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Lymphoma, Non-Hodgkin × Carmustine × Clear all
NCT06915246 2026-03-27

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

VIVUS LLC

Phase 2 Recruiting
49 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT03125642 2025-11-04

Auto Stem Cell Transplant for Lymphoma Patients

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
150 enrolled
LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡